Dec 03, 2025
Epilepsy affects nearly 50 million people globally, making it one of the most common neurological disorders, with about 80% of cases occurring in low- and middle-income countries where diagnostic and treatment resources are limited. Yet with timely and appropriate care, up to 70% of individuals with epilepsy can be...
Read More...
The Next Wave of Radioligand Therapies: 5 Candidates to Watch
Mar 20, 2026
Emerging TIL Therapies Poised to Broaden the Landscape Beyond AMTAGVI
Mar 06, 2026
BYSANTI Approval Positions Vanda to Compete in the Antipsychotic Market
Mar 02, 2026
Newsletter/Whitepaper